【对多囊卵巢综合征患者的总体饮食建议】
尽管PCOS女性患者肥胖患病率较高，但研究发现相当大比例的患者BMI正常。无论患者雄激素和肥胖水平如何，这些女性的血清胰岛素和胰岛素抵抗水平均有不同程度的升高。针对PCOS患者的一线治疗是肥胖女性应争取减少体重5%～10%，BMI正常或者体形偏瘦的患者，建议维持体重。由于胰岛素抵抗、血脂异常和高雄激素血症可能是由脂质诱导的促炎状态引发的，因此健康饮食模式对这些患者至关重要。如前所述，现阶段已经研究了各种饮食方案来治疗PCOS，但具体饮食处方的制定必须在全面评估患者健康水平的情况下开展，并根据患者的病情变化动态调整。
参考文献
[1] Stein I F, Leventhal M L. Amenorrhea associated with bilateral polycystic ovaries[J]. Am J Obstet Gynecol, 1935, 29(2):181-191.
[2] Azziz R, Carmin a E, D De wailly, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report[J]. Fertility & Sterility, 2009, 91(2):456-488.
[3] 陶弢, 王丽华. 多囊卵巢综合征诊治内分泌专家共识[J]. 中华内分泌代谢杂志，2018，34（01）：1-7.
[4] Knochenhauer E. S.Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study[J]. Journal of Clinical Endocrinology & Metabolism, 1998, 83(9):3078-3082.
[5] Kauあman R P, Baker V M, Dimarino P , et al. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: A comparison of two distinct populations[J]. American Journal of Obstetrics & Gynecology, 2002, 187(5):1362-1369.
[6] Rong L, Zhang Q, D Yang, et al. Prevalence of polycystic ovary syndrome in women in China: A large community-based study[J]. Human Reproduction, 2013, 28(9): 2562-2569.
[7] Wolf W M, Wattick R A, Kinkade O N, et al. Geographical Prevalence of Polycystic Ovary Syndrome as Determin ed by Region and Race/Ethnicity[J].International Journal of Environmental Research and Public Health, 2018, 15(11):2589.
[8] 左莉，傅亚均.多囊卵巢综合征病因及治疗进展[J].重庆医学，2018，47（09）：1247-1250.
[9] Hellas C, Luca C, Nappi R E. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists[J]. Journal of Clinical Endocrinology & Metabolism, 2020,105(8):e2695–e2709.
[10] Patel S.Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy[J].J Steroid Biochem Mol Biol, 2018, 182: 27-36.
[11] Faria FR, Gusmão LS, Faria ER, et al. Polycystic ovary syndrome and intervening factors in adolescents from 15 to 18 years old[J].Revista Da Associao Médica Brasileira, 2013, 59(4):341-346.
[12] Meier R K. Polycystic Ovary Syndrome[J]. Nurs Clin North Am. 2018, 53(3):407-420.
[13] Adriana N, Joop L, Helena T, et al. A Summary on Polycystic Ovary Syndrome: Diagnostic Criteria, Prevalence, Clinical Manifestations, and Management According to the Latest International Guidelines[J]. Semin ars in Reproductive Medicine, 2018, 36(01):5-12.
[14] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J]. Hum Reprod, 2004, 19(1): 41-47.
[15] Hoeger K M, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment[J]. J Clin Endocrinol Metab, 2021, 106(3): e1071-e1083.
[16] 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志，2018，01：2-6.
[17] 郁琦.多囊卵巢综合征诊治标准专家共识[J].中国实用妇科与产科杂志，2007，23（6）：474.
[18] Fauser B C, Tarlatzis B C, Rebar R W, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group [J]. Fertil Steril, 2012, 97(1): 28-38.e25.
[19] Goodman NF, Cobin RH, Futterweit W, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1 [J]. Endocr Pract, 2015, 21(11): 1291-1300.
[20] Woodward A, Klonizakis M, Broom D. Exercise and Polycystic Ovary Syndrome[J]. Adv Exp Med Biol, 2020, 1228: 123-136.
[21] Tan J, Wang QY, Feng GM, et al. Increased Risk of Psychiatric Disorders in Women with Polycystic Ovary Syndrome in Southwest China[J]. Chin Med J (Engl), 2017, 130(3): 262-266.(https://www.daowen.com)
[22] Wild R A, Caramin E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society[J]. The Journal of clinical endocrinology and metabolism ,2010,95(5):2038-2049.
[23] Teede HJ, Misso ML, Deeks AA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline[J]. Med J Aust, 2011, 195(6):65-112.
[24] 易强，李聪.多囊卵巢综合征的运动干预现状研究进展[J]. 现代医药卫生，2021，08：1306-1309.
[25] Benham J L , Yamamoto J M , Friedenreich C M , et al. Role of exercise training in polycystic ovary syndrome: a systematic review and meta‐analysis[J]. Clinical Obesity, 2018, 8(4):275-284.
[26] Kite C, Lahart IM, Afzal I, et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis[J]. Syst Rev. 2019，8(1):51.
[27] Moran L J, Tassone E C, Boyle J, et al. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management[J]. Obes Rev. 2020, 21(10):e13046.
[28] Greenwood EA, Noel MW, Kao CN, et al. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure[J]. Fertil Steril. 2016, 105(2):486-493.
[29] Moran L J, Noakes M, Clifton P, et al. Predictors of Lifestyle Intervention Attrition or Weight Loss Success in Women with Polycystic Ovary Syndrome Who Are Overweight or Obese[J]. Nutrients, 2019,11(3):145-148.
[30] Conway G, Dewailly D, Diamanti-Kandarakis E, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology[J]. Eur J Endocrinol, 2014, 171(4): 1-29.
[31] Lin A W, Kazemi M, Jarrett B Y, et al.Dietary and Physical Activity Behaviors in Women with Polycystic Ovary Syndrome per the New International Evidence-Based Guideline[J]. Nutrients, 2019, 11(11）:2711.
[32] 高金金，侯丽辉.超重/肥胖多囊卵巢综合征饮食疗法的研究进展[J].长春中医药大学学报，2016，32（05）：1089-1091.
[33] Faghfoori Z, Fazelian S, Shadnoush M, et al. Nutritional management in women with polycystic ovary syndrome: A review study[J]. Diabetes Metab Syndr, 2017, 11 Suppl 1: S429-S432.
[34] Moran L J, Ko H, Misso M,et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines[J]. J Acad Nutr Diet. 2013,113(4):520-545.
[35] Zhu H, Bi D, Zhang Y, et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations[35]. Signal Transduct Target Ther. 2022，7(1):11.
[36] Paoli A, Mancin L, Giacona MC, et al. Eあects of a ketogenic diet in overweight women with polycystic ovary syndrome[J]. J Transl Med. 2020，18(1):104.
[37] 江波，白文佩，郁琦，等.生酮饮食干预多囊卵巢综合征中国专家共识（2018年版）[J].实用临床医药杂志，2019，23（01）：1-4.
[38] Wolever T，Meynier A，Jenkins AL，et al． Glycemic index and insulinemic index of foods: an interlaboratory study using the ISO 2010 method[J].Nutrients，2019，11( 9) : 2218．
[39] Radulian G, Rusu E, Dragomir A, et al.Metabolic eあects of low glycaemic index diets[J].Nutrition Journal，2009，8: 5．
[40] 岳月仪，范雨佳，鲁燕.饮食模式对多囊卵巢综合征的影响[J].现代预防医学，2020，47（19）：3497-3499+3535.
[41] Xenou M, Gourounti K. Dietary Patterns and Polycystic Ovary Syndrome: a Systematic Review[J]. Maedica (Bucur), 2021, 16(3): 516-521..
[42] Furat Rencber S, Kurnaz Ozbek S, Eraldemır C, et al. Eあect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study[J]. J Ovarian Res, 2018, 11(1): 55.
[43] 洪忠新，丁冰杰．平衡膳食是防治原发性高血压病的基石［J］.中国全科医学，2017，20（3）：283-289．
[44] Esfandiari S，Bahadoran Z，Mirmiran P，et al．Adherence to the dietary approaches to stop hypertension trial (DASH) diet is inversely associated with incidence of insulin resistance in adults: the Tehran lipid and glucose study[J]. J Clin Biochem Nutr, 2017, 61(2): 123-129.